Gene · 4595
Papers3,741
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 3,741
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Malignant Perivascular Epithelioid Cell Tumor (PEComa) of the Uterus as Part of the Hereditary Cancer Syndrome: A Case Diagnosed with Multiple Malignancies. | Turk Patoloji Derg | 2023 | 36367123 | PubTator, text mining | PubMed |
| Somatic inactivation of breast cancer predisposition genes in tumors associated with pathogenic germline variants. | J Natl Cancer Inst | 2023 | 36315097 | PubTator, text mining | PubMed |
| Germline mutations in WNK2 could be associated with serrated polyposis syndrome. | J Med Genet | 2023 | 36270769 | PubTator, text mining | PubMed |
| Summary of the experiences, knowledge, medical management, and family communication of monoallelic MUTYH carriers. | J Genet Couns | 2023 | 36245263 | PubTator, text mining | PubMed |
| SCLC: Epidemiology, Risk Factors, Genetic Susceptibility, Molecular Pathology, Screening, and Early Detection. | J Thorac Oncol | 2023 | 36243387 | PubTator, text mining | PubMed |
| Integration of Universal Germline Genetic Testing for All New Breast Cancer Patients. | Ann Surg Oncol | 2023 | 36161375 | PubTator, text mining | PubMed |
| Multiple basal cell carcinomas revealing a biallelic MUTYH gene mutation in a 39-year-old male patient. | J Eur Acad Dermatol Venereol | 2023 | 36151995 | PubTator, text mining | PubMed |
Intraabdominal sporadic desmoid tumors and inflammation: an updated literature review and presentation and insights on pathogenesis of synchronous sporadic mesenteric desmoid tumors occurring after surgery for necrotizing pancreatitis. | Clin Exp Med | 2023 | 35913675 | PubTator, text mining | PubMed |
| Mainstreaming germline genetic testing for patients with pancreatic cancer increases uptake. | Fam Cancer | 2023 | 35713757 | PubTator, text mining | PubMed |
| Genomic Signatures from Clinical Tumor Sequencing in Patients with Breast Cancer Having Germline BRCA1/2 Mutation. | Cancer Res Treat | 2023 | 35681111 | PubTator, text mining | PubMed |
| A large family with MSH3-related polyposis. | Fam Cancer | 2023 | 35675019 | PubTator, text mining | PubMed |
| MUTYH is a potential prognostic biomarker and correlates with immune infiltrates in hepatocellular carcinoma. | Liver Res | 2022 | 39957908 | PubTator, text mining | PubMed |
| Under-Representation of Racial Groups in Genomics Studies of Gastroenteropancreatic Neuroendocrine Neoplasms. | Cancer Res Commun | 2022 | 36969744 | PubTator, text mining | PubMed |
| Li-Fraumeni-associated pancreatic neuroendocrine tumour and XAF1 p.Glu134Ter risk modifier variant. | Ecancermedicalscience | 2022 | 36819813 | PubTator, text mining | PubMed |
Comprehensive genomic profiling of upper tract urothelial carcinoma and urothelial carcinoma of the bladder identifies distinct molecular characterizations with potential implications for targeted therapy & immunotherapy. | Front Immunol | 2022 | 36818471 | PubTator, text mining | PubMed |
| HROP68: A rare case of medullary pancreatic cancer-characterization and chemosensitivity of the first patient-derived cell line. | Front Oncol | 2022 | 36761421 | PubTator, text mining | PubMed |
| Assessing the pathogenicity of BRCA1/2 variants of unknown significance: Relevance and challenges for breast cancer precision medicine. | Front Oncol | 2022 | 36741700 | PubTator, text mining | PubMed |
| The gene signature of tertiary lymphoid structures within ovarian cancer predicts the prognosis and immunotherapy benefit. | Front Genet | 2022 | 36704336 | PubTator, text mining | PubMed |
| Editorial: Somatic mutations, genome mosaicism and aging. | Front Aging | 2022 | 36698749 | PubTator, text mining | PubMed |
| Using publicly available datasets to identify population-based transcriptomic landscape contributing to the aggressiveness of breast cancer in young women. | Front Genet | 2022 | 36685821 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4595/papers?page=32